OASYS NOW addresses the inefficiencies in drug development by offering an innovative platform, GRIP, serving as a digital Waiting Room for patients awaiting new treatments through clinical trials. With an impressive team and notable achievements, including substantial funding and partnerships, OASYS NOW strategically positions itself in the growing 86 billion dollar clinical trial market, demonstrating a strong focus on a patient-centric approach and promising growth opportunities.

ASIF Ventures Investments: 2023

Website: OASYS NOW